Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Scand J Immunol ; 70(1): 10-7, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19522762

ABSTRACT

To better understand the interactions between opportunistic fungi and their hosts, we investigated hydrogen peroxide (H2O2), nitric oxide and TNF-alpha production by peritoneal macrophages from Ehrlich tumour-bearing mice (TBM) during microbial infections. For this purpose, TBM at days 7, 14 and 21 of tumour progression were inoculated intraperitoneally with C. albicans and evaluated after 24 and 72 h. We observed that TBM showed significant increases in H2O2, TNF-alpha levels and fungal clearance at day 7 after C. albicans infection. However, as the tumour advanced, there was a progressive decline in the release of H2O2 and TNF-alpha that was paired with the dissemination of C. albicans. These results demonstrate that protective macrophage activities against Candida albicans are limited to the initial stages of tumour growth; continued solid tumour growth weakened the macrophage response and as a consequence, weakened the host's susceptibility to opportunistic infections.


Subject(s)
Candidiasis/complications , Candidiasis/immunology , Carcinoma, Ehrlich Tumor/complications , Carcinoma, Ehrlich Tumor/immunology , Macrophages, Peritoneal/immunology , Opportunistic Infections/complications , Animals , Candida albicans , Hydrogen Peroxide/metabolism , Macrophages, Peritoneal/metabolism , Male , Mice , Nitric Oxide/biosynthesis , Opportunistic Infections/immunology , Tumor Necrosis Factor-alpha/biosynthesis
2.
Ann Trop Med Parasitol ; 98(2): 121-7, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15035722

ABSTRACT

It is essential for malariologists and researchers to have simple and accurate means of assessing the threat of Plasmodium parasites. An attempt was therefore made to re-standardize one of the circumsporozoite (CS) ELISA that can be used to detect and quantify the circumsporozoite antigens of P. falciparum and P. vivax. A two-site, 'sandwich' ELISA based on a monoclonal antibody was used to test for the CS antigen and sporozoites of each Plasmodium species simultaneously. Using the resultant optical-density values, standard curves, that permit the number of sporozoites in an infected mosquito to be estimated from the quantification of the CS antigen, were constructed. Using these plots and the CS ELISA, the presence of just 12.5 sporozoites (i.e. 0.8 pg CS antigen) of P. falciparum, four sporozoites (3.2 pg antigen) of P. vivax-210 or 12.5 sporozoites (32.0 pg antigen) of P. vivax-247 could be demonstrated.


Subject(s)
Anopheles/immunology , Antigens, Protozoan/analysis , Plasmodium falciparum/immunology , Plasmodium vivax/immunology , Sporozoites/immunology , Animals , Anopheles/parasitology , Enzyme-Linked Immunosorbent Assay/methods , Insect Vectors/immunology , Insect Vectors/parasitology , Protozoan Proteins/analysis , Sensitivity and Specificity
3.
Rev Inst Med Trop Sao Paulo ; 43(1): 29-32, 2001.
Article in English | MEDLINE | ID: mdl-11246280

ABSTRACT

This study presents the results of T. mentagrophytes inoculation in the cheek pouch of the hamster, an immunologically privileged site. Forty two animals were used: 21 inoculated with 10(6) fungi in the cheek pouch (group 1) and 21 inoculated initially with 10(6) fungi in the foot pad and 15 days later in the cheek pouch, with the same amount of fungi (group 2). Animals were sacrificed at 20 hours, 3, 7, 14, 30, 60, and 120 days; samples from inoculated cheek pouch, and foot pads submitted to the foot pad test (FPT), were collected. Independent of group and time of evolution of infection, animals did not develop delayed hypersensitivity evaluated through the FPT. The pre-inoculation of fungi in the foot pad did not change the morphology of lesions induced in the cheek pouch. Therefore, in animals of group 1 and 2, the introduction of the fungus in the cheek pouch resulted in focal lesion composed of a sterile acute inflammatory infiltrate, with abscess formation that evolved to a macrophagic reaction, and later to resolution even in the absence of immune response detectable by FPT. Our results indicate that in spite of the important role of the immune response in the spontaneous regression of dermatophytosis, other factors are also an integral part in the defense against this fungal infection.


Subject(s)
Dermatomycoses/immunology , Tinea/immunology , Trichophyton , Animals , Cheek , Cricetinae , Dermatomycoses/microbiology , Dermatomycoses/pathology , Male , Tinea/microbiology
4.
Proc Natl Acad Sci U S A ; 97(15): 8272-7, 2000 Jul 18.
Article in English | MEDLINE | ID: mdl-10890904

ABSTRACT

The invasive signal amplification reaction has been previously developed for quantitative detection of nucleic acids and discrimination of single-nucleotide polymorphisms. Here we describe a method that couples two invasive reactions into a serial isothermal homogeneous assay using fluorescence resonance energy transfer detection. The serial version of the assay generates more than 10(7) reporter molecules for each molecule of target DNA in a 4-h reaction; this sensitivity, coupled with the exquisite specificity of the reaction, is sufficient for direct detection of less than 1,000 target molecules with no prior target amplification. Here we present a kinetic analysis of the parameters affecting signal and background generation in the serial invasive signal amplification reaction and describe a simple kinetic model of the assay. We demonstrate the ability of the assay to detect as few as 600 copies of the methylene tetrahydrofolate reductase gene in samples of human genomic DNA. We also demonstrate the ability of the assay to discriminate single base differences in this gene by using 20 ng of human genomic DNA.


Subject(s)
DNA, Viral/genetics , Hepatitis B virus/genetics , Polymorphism, Genetic , Base Sequence , DNA, Viral/analysis , Humans , Kinetics , Molecular Sequence Data , Nucleic Acid Amplification Techniques
5.
Genome Res ; 10(3): 330-43, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10720574

ABSTRACT

Large-scale pharmacogenetics and complex disease association studies will require typing of thousands of single-nucleotide polymorphisms (SNPs) in thousands of individuals. Such projects would benefit from a genotyping system with accuracy >99% and a failure rate <5% on a simple, reliable, and flexible platform. However, such a system is not yet available for routine laboratory use. We have evaluated a modification of the previously reported Invader SNP-typing chemistry for use in a genotyping laboratory and tested its automation. The Invader technology uses a Flap Endonuclease for allele discrimination and a universal fluorescence resonance energy transfer (FRET) reporter system. Three hundred and eighty-four individuals were genotyped across a panel of 36 SNPs and one insertion/deletion polymorphism with Invader assays using PCR product as template, a total of 14,208 genotypes. An average failure rate of 2.3% was recorded, mostly associated with PCR failure, and the typing was 99.2% accurate when compared with genotypes generated with established techniques. An average signal-to-noise ratio (9:1) was obtained. The high degree of discrimination for single base changes, coupled with homogeneous format, has allowed us to deploy liquid handling robots in a 384-well microtitre plate format and an automated end-point capture of fluorescent signal. Simple semiautomated data interpretation allows the generation of approximately 25,000 genotypes per person per week, which is 10-fold greater than gel-based SNP typing and microsatellite typing in our laboratory. Savings on labor costs are considerable. We conclude that Invader chemistry using PCR products as template represents a useful technology for typing large numbers of SNPs rapidly and efficiently.


Subject(s)
Polymerase Chain Reaction/methods , Polymorphism, Single Nucleotide/genetics , Base Sequence , Diabetes Mellitus, Type 1/genetics , Endodeoxyribonucleases/chemistry , Flap Endonucleases , Genetic Predisposition to Disease , Genetic Testing/instrumentation , Genetic Testing/methods , Genotype , Humans , Molecular Sequence Data , Oligonucleotide Probes/chemistry , Polymerase Chain Reaction/instrumentation , Sequence Analysis, DNA/instrumentation , Sequence Analysis, DNA/methods , Spectrometry, Fluorescence , Templates, Genetic
6.
Phytopathology ; 90(7): 758-61, 2000 Jul.
Article in English | MEDLINE | ID: mdl-18944495

ABSTRACT

ABSTRACT New cultivars of the common bean (Phaseolus vulgaris) with durable resistance to anthracnose can be developed by pyramiding major resistance genes using marker-assisted selection. To this end, it is necessary to identify sources of resistance and molecular markers tightly linked to the resistance genes. The objectives of this work were to study the inheritance of resistance to anthracnose in the cultivar TO (carrying the Co-4 gene), to identify random amplified polymorphic DNA (RAPD) markers linked to Co-4, and to introgress this gene in the cultivar Rudá. Populations F(1), F(2), F(2:3), BC(1)s, and BC(1)r from the cross Rudá x TO were inoculated with race 65 of Colletotrichum lindemuthianum, causal agent of bean anthracnose. The phenotypic ratios (resistant/susceptible) were 3:1 in the F(2) population, 1:1 in the BC(1)s, and 1:0 in the BC(1)r, confirming that resistance to anthracnose in the cultivar TO was monogenic and dominant. Six RAPD markers linked to the Co-4 gene were identified, four in the coupling phase: OPY20(830C) (0.0 centimorgan [cM]), OPC08(900C) (9.7 cM), OPI16(850C) (14.3 cM), and OPJ01(1,380C) (18.1 cM); and two in the repulsion phase: OPB03(1,800T) (3.7 cM) and OPA18(830T) (17.4 cM). OPY20(830C) and OPB03(1,800T), used in association as a codominant pair, allowed the identification of the three genotypic classes with a high degree of confidence. Marker OPY20(830C), which is tightly linked to Co-4, is being used to assist in breeding for resistance to anthracnose.

7.
Electrophoresis ; 20(6): 1131-40, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10380752

ABSTRACT

The removal of impurities and contaminants from PCR-amplified fragments is important for mutation detection methods which identify mutations based on shifts in electrophoretic mobility. This is particularly critical for assays and detection methods which use target DNA that is labeled prior to analysis and electrophoretic detection. We examined several procedures for purifying DNA amplified by the polymerase chain reaction (PCR) and their use in conjunction with a novel DNA scanning method, the Cleavase fragment length polymorphism (CFLP)* assay. In this study, a 480 bp DNA fragment, fluorescently labeled on the 5'-end of one strand, was amplified and subjected to various widely used purification procedures, including several commercially available clean-up kits. We demonstrate that visualization of the fluorescent label, as opposed to simple ethidium bromide staining, reveals the presence of considerable levels of labeled, truncated, amplification products. The various procedures were evaluated on the basis of their ability to remove these unwanted DNA fragments as well as on the degree to which they inhibited or promoted the CFLP reaction. Several procedures are recommended for use with CFLP analysis, including isopropanol precipitation, gel excision, and several commercially available spin columns. Concurrently, we evaluated (compared) a number of commonly used visualization platforms, including fluorescence imaging, chemiluminescence, and post-electrophoretic staining, for the ability to detect CFLP pattern changes. The advantages and disadvantages of different methods are discussed and amounts of DNA to be used for CFLP analysis on different detection platforms are recommended.


Subject(s)
DNA/isolation & purification , Endodeoxyribonucleases/metabolism , Polymerase Chain Reaction/methods , Polymorphism, Restriction Fragment Length , Tumor Suppressor Protein p53/genetics , Humans , Tumor Cells, Cultured
8.
Electrophoresis ; 20(6): 1211-23, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10380761

ABSTRACT

We have generated a collection of clones containing single point mutations within the exon 5-9 hot spot regions of the p53 gene by using polymerase chain reaction (PCR) to amplify select regions of the gene from characterized cell lines. These clones were then used to address the sensitivity of mutation detection using slab-gel single-strand conformation polymorphism (SSCP) and Cleavase fragment length polymorphism (CFLP) assay systems. Both methods exhibited high sensitivities for the detection of mutations in cloned p53 mutations in this study: 97% for CFLP and 94% for SSCP. In addition to resulting in higher sensitivity of mutation detection, CFLP has the capability to analyze longer fragments. In this study, CFLP identified five intronic mutations which were not investigated in the exon-specific SSCP assay. These results agree with those found elsewhere and demonstrate that CFLP scanning can have practical advantages when used for the identification of sequence alterations within the p53 gene.


Subject(s)
Genes, p53 , Mutation , Polymerase Chain Reaction/methods , Polymorphism, Single-Stranded Conformational , Humans , Plasmids , Reproducibility of Results , Sensitivity and Specificity , Sequence Analysis, DNA/methods
9.
Nat Biotechnol ; 17(3): 292-6, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10096299

ABSTRACT

Flap endonucleases (FENs) isolated from archaea are shown to recognize and cleave a structure formed when two overlapping oligonucleotides hybridize to a target DNA strand. The downstream oligonucleotide probe is cleaved, and the precise site of cleavage is dependent on the amount of overlap with the upstream oligonucleotide. We have demonstrated that use of thermostable archaeal FENs allows the reaction to be performed at temperatures that promote probe turnover without the need for temperature cycling. The resulting amplification of the cleavage signal enables the detection of specific DNA targets at sub-attomole levels within complex mixtures. Moreover, we provide evidence that this cleavage is sufficiently specific to enable discrimination of single-base differences and can differentiate homozygotes from heterozygotes in single-copy genes in genomic DNA.


Subject(s)
DNA/metabolism , Oligonucleotide Probes , Polymorphism, Restriction Fragment Length , Archaeoglobus fulgidus/genetics , Bacteriophage M13/genetics , DNA/isolation & purification , Endonucleases/genetics , Exodeoxyribonuclease V , Exodeoxyribonucleases/genetics , Leukocytes/metabolism , Models, Biological , Mutagenesis, Insertional , Pyrococcus furiosus/genetics , Spectrometry, Fluorescence
10.
Mol Diagn ; 4(4): 353-64, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10671646

ABSTRACT

The Invader technology has been developed for the detection of nucleic acids. It is a signal amplification system able to accurately quantify DNA and RNA targets with high sensitivity. Exquisite specificity is achieved by combining hybridization with enzyme recognition, which provides the ability to discriminate mutant from wild-type at ratios greater than 1/1000 (mutant/wt). The technology is isothermal and flexible and incorporates a homogeneous fluorescence readout. It is therefore readily adaptable for use in clinical reference laboratories, as well as high-throughput applications using 96-, 384-, and 1,536-well microtiter plate formats. The molecular mechanism of the system and specific applications for use in clinical and research laboratories are described. These include direct analysis of unamplified human genomic DNA to detect mutations and single-nucleotide polymorphisms associated with factor V Leiden, factor II, cystic fibrosis, and apolipoprotein E, and gene expression assays that quantify messenger RNA levels in cells using direct lysates.


Subject(s)
Nucleic Acid Amplification Techniques , Pharmacogenetics , Clinical Laboratory Techniques , DNA/analysis , DNA Mutational Analysis , Enzymes/chemistry , Humans , RNA/analysis
11.
Biochemistry ; 37(50): 17571-8, 1998 Dec 15.
Article in English | MEDLINE | ID: mdl-9860873

ABSTRACT

Cemadotin (LU103793) (NSC D-669356) is a water-soluble synthetic analogue of dolastatin 15 that inhibits cell proliferation in vitro and the growth of human tumor xenografts. Cemadotin is in phase II clinical trials as a promising cancer chemotherapeutic agent. The drug blocks cells at mitosis. Its primary mode of action has been unclear but is believed to involve an action on microtubules. We have found that cemadotin binds to tubulin and strongly suppresses microtubule dynamics. Scatchard analysis of cemadotin binding to tubulin indicated that there are two affinity classes of cemadotin-binding sites with Kd values of 19.4 microM and 136 microM. Cemadotin did not inhibit the binding of vinblastine to tubulin, and, conversely, vinblastine did not inhibit the binding of cemadotin to tubulin. By quantitative video microscopy of individual microtubules, we found that cemadotin strongly suppressed dynamic instability of microtubules assembled to steady state using bovine brain tubulin devoid of microtubule-associated proteins. It reduced the rate and extent of growing and shortening, increased the rescue frequency, and increased the percentage of time the microtubules spent in an attenuated or paused state, neither growing nor shortening detectably. At the lowest effective cemadotin concentrations, dynamics were suppressed in the absence of significant microtubule depolymerization. The results suggest that cemadotin exerts its antitumor activity by suppressing spindle microtubule dynamics through a distinct molecular mechanism by binding at a novel site in tubulin.


Subject(s)
Antineoplastic Agents/metabolism , Microtubules/metabolism , Oligopeptides/metabolism , Tubulin/metabolism , Animals , Antineoplastic Agents/pharmacology , Binding Sites , Brain , Cattle , Growth Inhibitors/metabolism , Growth Inhibitors/pharmacology , Microtubules/chemistry , Microtubules/drug effects , Oligopeptides/pharmacology , Protein Binding , Protein Conformation/drug effects , Tubulin/chemistry
12.
J Clin Microbiol ; 36(7): 1895-901, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9650932

ABSTRACT

This study was designed to analyze the feasibility and validity of using Cleavase Fragment Length Polymorphism (CFLP) analysis as an alternative to DNA sequencing for high-throughput screening of hepatitis C virus (HCV) genotypes in a high-volume molecular pathology laboratory setting. By using a 244-bp amplicon from the 5' untranslated region of the HCV genome, 61 clinical samples received for HCV reverse transcription-PCR (RT-PCR) were genotyped by this method. The genotype frequencies assigned by the CFLP method were 44.3% for type 1a, 26.2% for 1b, 13.1% for type 2b, and 5% type 3a. The results obtained by nucleotide sequence analysis provided 100% concordance with those obtained by CFLP analysis at the major genotype level, with resolvable differences as to subtype designations for five samples. CFLP analysis-derived HCV genotype frequencies also concurred with the national estimates (N. N. Zein et al., Ann. Intern. Med. 125:634-639, 1996). Reanalysis of 42 of these samples in parallel in a different research laboratory reproduced the CFLP fingerprints for 100% of the samples. Similarly, the major subtype designations for 19 samples subjected to different incubation temperature-time conditions were also 100% reproducible. Comparative cost analysis for genotyping of HCV by line probe assay, CFLP analysis, and automated DNA sequencing indicated that the average cost per amplicon was lowest for CFLP analysis, at $20 (direct costs). On the basis of these findings we propose that CFLP analysis is a robust, sensitive, specific, and an economical method for large-scale screening of HCV-infected patients for alpha interferon-resistant HCV genotypes. The paper describes an algorithm that uses as a reflex test the RT-PCR-based qualitative screening of samples for HCV detection and also addresses genotypes that are ambiguous.


Subject(s)
Algorithms , Hepacivirus/genetics , Hepatitis C/virology , Interferon-alpha/pharmacology , Costs and Cost Analysis , DNA Fingerprinting , Drug Resistance, Microbial/genetics , Endonucleases/metabolism , Genetic Techniques/economics , Genotype , Hepacivirus/classification , Hepacivirus/isolation & purification , Hepatitis C/epidemiology , Humans , Polymorphism, Genetic , Sensitivity and Specificity , Sequence Analysis, DNA , Substrate Specificity
14.
J Clin Microbiol ; 35(12): 3156-62, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9399512

ABSTRACT

We describe the application of a new DNA-scanning method, which has been termed Cleavase Fragment Length Polymorphism (CFLP; Third Wave Technologies, Inc., Madison, Wis.), for the determination of the genotype of hepatitis C virus (HCV). CFLP analysis results in the generation of structural fingerprints that allow discrimination of different DNA sequences. We analyzed 251-bp cDNA products generated by reverse transcription-PCR of the well-conserved 5'-noncoding region of HCV. We determined the genotypes of 87 samples by DNA sequencing and found isolates representing 98% of the types typically encountered in the United States, i.e., types 1a, 1b, 2a/c, 2b, 3a, and 4. Blinded CFLP analysis of these samples was 100% concordant with DNA sequencing results, such that closely related genotypes yielded patterns with strong familial resemblance whereas more divergent sequences yielded patterns with pronounced dissimilarities. In each case, the aggregate pattern was indicative of genotypic grouping, while finer changes suggested subgenotypic differences. We also assessed the reproducibility of CFLP analysis in HCV genotyping by analyzing three distinct isolates belonging to a single subtype. These three isolates yielded indistinguishable CFLP patterns, as did replicate analysis of a single isolate. This study demonstrates the suitability of this technology for HCV genotyping and suggests that it may provide a low-cost, high-throughput alternative to DNA sequencing or other, more costly or cumbersome genotyping approaches.


Subject(s)
Genetic Techniques , Hepacivirus/genetics , Polymorphism, Genetic , Base Sequence , DNA Fingerprinting , DNA Primers/genetics , DNA, Complementary/genetics , DNA, Viral/genetics , DNA, Viral/isolation & purification , Genetic Variation , Genotype , Hepacivirus/isolation & purification , Hepatitis C/epidemiology , Hepatitis C/virology , Humans , Molecular Epidemiology , Molecular Sequence Data , Polymerase Chain Reaction , Reproducibility of Results , United States/epidemiology
15.
Ann Trop Med Parasitol ; 90(2): 135-43, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8762403

ABSTRACT

Data on the seroprevalences of Plasmodium falciparum, P. vivax, and P. malariae in four isolated Indian tribes of the Amazon basin in Brazil, as determined by IFAT, were re-analysed. Age-, sex- and tribe-specific geometric mean antibody titres and externally standardized prevalence ratios were calculated for each parasite species. Correlation coefficients and prevalence odds ratios were also calculated for multiple infections with different combinations of the three Plasmodium species. Titres of all but one of the antibodies studied were similar in males and females; titres of antibodies to the blood stages of P. malariae were slightly higher in females than in males. Titres of antibodies to all three Plasmodium species increased with subject age, and this age effect was not confounded by sex or tribal differences. There were striking differences between tribes, with the Parakana tribe having relatively low titres of antibodies against P. falciparum and P. malariae; these tribal effects were not confounded by sex or age differences between tribes. The results indicate that conditions conductive to the transmission of P. malariae exist in this region of the Amazon. The potential for zoonotic transmission of P. brasilianum, a parasite of monkeys which is morphologically similar to P. malarie, and the generally high rates of seropositivity to all three species of Plasmodium indicate that control measures which are adequate and applicable to the region studied need to be developed.


Subject(s)
Indians, South American , Malaria/ethnology , Adolescent , Adult , Age Distribution , Animals , Brazil/epidemiology , Child , Child, Preschool , Female , Humans , Infant , Malaria/epidemiology , Male , Parasitemia/epidemiology , Plasmodium falciparum/isolation & purification , Plasmodium malariae/isolation & purification , Plasmodium vivax/isolation & purification , Prevalence , Sex Distribution
16.
Cancer Res ; 55(14): 3085-92, 1995 Jul 15.
Article in English | MEDLINE | ID: mdl-7606731

ABSTRACT

LU103793 (NSC D-669356) is a new synthetic derivative of Dolastatin 15, an antiproliferative compound which was isolated from the mollusk Dolabella auricularia. Like Dolastatin 15, LU103793 is highly cytotoxic in vitro (IC50 = 0.1 nM). To investigate the mechanism of action of LU103793, we used a combination of biochemical and cellular methods. Turbidity assays with bovine brain microtubules demonstrated that LU103793 inhibits microtubule polymerization in a concentration-dependent manner (IC50 = 7 microM). Treatment with this compound also induced depolymerization of preassembled microtubules. Cell cycle analysis of tumor cell lines treated with LU103793 indicated a block in the G2-M phase. At the cellular level, it induced depolymerization of microtubules in interphase cells and development of abnormal spindles and chromosome distribution in mitotic cells. Although these effects are very similar to the cellular alterations caused by vinblastine, LU103793 does not inhibit vinblastine binding to unpolymerized tubulin in vitro. Our results suggest that LU103793 exerts its cytotoxic activity primarily through disruption of microtubule organization.


Subject(s)
Antineoplastic Agents/pharmacology , Microtubules/drug effects , Mitosis/drug effects , Neoplasms/drug therapy , Oligopeptides/pharmacology , Adenocarcinoma/drug therapy , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Amino Acid Sequence , Breast Neoplasms/drug therapy , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Cell Cycle/drug effects , Cell Division/drug effects , Chromosomes, Human/drug effects , Colonic Neoplasms/drug therapy , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , Drug Interactions , Guanosine Triphosphate/metabolism , HeLa Cells , Humans , Hydrolysis , Molecular Sequence Data , Neoplasms/metabolism , Neoplasms/pathology , Tubulin/metabolism , Tumor Cells, Cultured/drug effects , Vinblastine/metabolism , Vinblastine/pharmacology
17.
Rev Inst Med Trop Sao Paulo ; 37(4): 303-9, 1995.
Article in English | MEDLINE | ID: mdl-8599058

ABSTRACT

The hamster cheek pouch is an invagination of oral mucosa, characterized histologically as skin-like. In this paper we describe anatomical, histological and embriological features of the pouch and comment on the pouch as an immunologically privileged site since it lacks lymphatic drainage and has few Langerhans cells. We present the review from literature and our observations after inoculation in the pouch of mycobacteriae (BCG, Mycobacterium tuberculosis and Mycobacterium leprae) and a fungus (Paracoccidioides brasiliensis). Lesions in the pouch were granulomatous but smaller and long lasting; even granulomatous, the reaction was inefficient to control the proliferation of agents compared with inoculation in other sites, except for BCG. Appearance of immunity was also delayed or absent and, when it was detected, a sharp decrease in number of agents in pouch lesions was observed. These observations make the pouch an interesting site for the study of the role of immune system in infectious diseases and in granuloma formation.


Subject(s)
Cricetinae , Granuloma/immunology , Mouth Mucosa/immunology , Animals , Cheek , Disease Models, Animal , Granuloma/microbiology , Granuloma/pathology , Mouth Mucosa/pathology , Mycobacterium/immunology , Paracoccidioides/immunology
18.
Rev Soc Bras Med Trop ; 28(3): 233-6, 1995.
Article in Portuguese | MEDLINE | ID: mdl-7480918

ABSTRACT

In this study the immunopotentiator levamisole as well as a mixture of BCG/Mycobacterium leprae were investigated in inactive lepromatous leprosy patients by using the Mitsuda reaction as a parameter. Twenty lepromatous patients ten years ago classified as histologically negative for Mitsuda's test were divided into three groups: five patients that were only retested with Mitsuda antigen; eight patients that received oral levamisol and seven patients that received a mixture of alive BCG plus autoclaved M. leprae. The results indicated that: 1) the levamisole did not alter the reactivity to lepromin in any of the patients studied; 2) neither the changes in the reactivity to lepromin by using the mixture (3 cases) nor those that occurred spontaneously (3 cases) were clear. They properly reflected the natural variation of patients with some degree of resistance to Mycobacterium leprae.


Subject(s)
Adjuvants, Immunologic/therapeutic use , BCG Vaccine/therapeutic use , Immunotherapy , Leprosy/immunology , Levamisole/therapeutic use , Mycobacterium leprae , Bacterial Vaccines/therapeutic use , Humans , Leprosy/therapy
20.
Arq Neuropsiquiatr ; 52(1): 64-8, 1994 Mar.
Article in English | MEDLINE | ID: mdl-8002810

ABSTRACT

The authors describe a rare case of increased intracranial hypertension consequent to a spinal cervical glioblastoma multiforme in a young patient. They analyse the physiopathology of intracranial hypertension in spinal tumors and the rarity of such kind of tumor in this location, and its clinico-pathological aspects.


Subject(s)
Glioblastoma/complications , Pseudotumor Cerebri/etiology , Spinal Cord Neoplasms/complications , Adult , Female , Glioblastoma/pathology , Humans , Spinal Cord Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...